INTRODUCTION
============

The limbic system-associated membrane protein (LSAMP) gene gives rise to LAMP, which is a 64- to 68-kDa heavily glycosylated protein, structurally characterized by three immunoglobulin (Ig) domains ([@B20]). LAMP protein is expressed on the surface of somata and proximal dendrites of neurons ([@B25]) where it integrates via glycosyl-phosphatidyl-inositol (GPI) anchor ([@B20]). LAMP protein has been shown to be specific to the cortical and sub-cortical limbic-associated regions (e.g., perirhinal cortex, cingulate cortex, amygdala, hippocampus, and striatum) of the developing and adult brain ([@B15]; [@B5]; [@B20]; [@B23]). Despite the name, LAMP is not expressed only in the limbic-associated areas, but also less intensely in the midbrain and hindbrain regions ([@B23]). A 99% amino acid sequence identity between human and rodent LAMP ([@B20]) indicates strong phylogenetic conservation of the protein structure and associated functional properties. Several cell culture experiments suggest that LAMP mediates axon targeting and growth in the brain ([@B9]; [@B21]; [@B16]; [@B4]).

FUNCTIONAL STUDIES DEMONSTRATING A ROLE OF THE Lsamp GENE IN THE REGULATION OF EMOTIONAL BEHAVIOR
=================================================================================================

The first evidence for a role of the Lsamp gene in the regulation of emotional behavior came from a study where male Wistar rats were selected according to their exploratory behavior in the elevated plus-maze model of anxiety. Animals with lower exploratory activity (increased anxiety) had elevated levels of the Lsamp transcript in the periaqueductal gray ([@B19]). In the same rats, an increase of Lsamp gene expression was also noticed in the amygdala, but not in the frontal cortex ([@B18]). Exposure of rats to cat odor, another model of anxiety in rodents, also increased the expression of Lsamp transcript in the amygdala ([@B12]). These findings were extended by [@B1] demonstrating that the transcript for Lsamp was more expressed in the raphe, hippocampus, and frontal cortex of rats displaying reduced exploratory activity in the motility box. [@B14] established that fear conditioning caused changes in the Lsamp transcript expression in the amygdala of rats. Altogether, rodent studies indicate that increased level of the Lsamp transcript in several brain areas is related with increased trait anxiety ([@B19],[@B18]; [@B1]), acute fear reaction ([@B12]), and fear conditioning ([@B14]).

EVIDENCE FROM STUDIES WITH Lsamp-DEFICIENT MICE SUPPORTING ITS ROLE IN THE REGULATION OF EMOTIONAL BEHAVIOR
===========================================================================================================

Two different Lsamp gene knockout mouse lines have been created. The first ([@B3]) was created by deleting exon 2 and the mice were back-crossed more than 10 generations onto the C57BL/6J background. The second ([@B7]) was created by our research team by deleting exon 1b and we used F2 hybrids \[(129S6/SvEvTac × C57BL/6) × (129S6/SvEvTac × C57BL/6)\] for the behavioral experiments, because the congenic footprint effect does not allow to achieve a pure background by backcrossing and besides, it has been argued that a robust behavioral phenotype, detectable over and above the behavioral variability caused by a mixed genetic background, obviates the need for back-crosses ([@B24]). Several cell culture experiments suggest that LAMP mediates axon targeting and growth in the brain ([@B9]; [@B16]; [@B4]). However, obvious lack of deviations in the brain organization of Lsamp-deficient mouse line, lacking exon 2 of the Lsamp gene, revealed that LAMP is rather mediating finely specialized aspects of circuit formation and maturation of the limbic system ([@B3]). These two mouse lines have remarkably similar phenotypes: both display no changes in sensory and motor development, are slightly hyperactive in novel environments, and perform more open arm entries and head-dips, and spend more time on open arms in the elevated plus-maze. However, there are also differences between the phenotypes: the first Lsamp gene knockout mouse line, generated in the Vanderbilt University (U.S.A.), exhibited a pronounced deficit in spatial memory acquisition in the water maze and poorly sustained CA1 long-term potentiation ([@B22]). The second Lsamp gene knockout mouse line, generated by us, performed normally in the water maze and also displayed no learning deficiencies in the active avoidance test, another learning paradigm ([@B7]). We have also seen several unique phenotypic differences in our Lsamp gene knockout mice, such as decreased body weight, lack of whisker trimming, decreased aggressive behavior and reduced swimming speed ([@B7]). A possible explanation for the reduced agonistic and aggressive behavior could be the increased tone of 5-hydroxytryptamine (5-HT) system in the forebrain structures established in male Lsamp-deficient mice ([@B6]).

In the pharmacological studies we have found that the anxiolytic effect of diazepam is stronger in Lsamp-deficient mice compared to their wild-type littermates. Moreover, the ratio of GABA~A~ receptor subunit genes is shifted in favor of the alpha2 subunit compared to the alpha1 subunit in the temporal lobe of Lsamp-deficient mice. This could be a possible reason for the reduced anxiety as well as the increased anxiolytic effect of diazepam in Lsamp-deficient mice ([@B7]). Besides that the motor stimulant effect of amphetamine was significantly weaker in young Lsamp-deficient mice ([@B6]). Moreover, amphetamine did not cause place preference in these mice. The reduced action of amphetamine was accompanied by reduced expression of dopamine transporter, a major target of amphetamine, gene in the mesencephalon. The reduced behavioral effects were accompanied by increased levels and reduced turnover of 5-HT in the forebrain structures in response to amphetamine administration ([@B6]). Altogether, our recent pharmacological and biochemical studies point toward changes in the function of GABA-, 5-HT-, and dopaminergic systems in Lsamp-deficient mice.

INFLUENCE OF ENVIRONMENTAL MANIPULATIONS ON THE BEHAVIOR OF Lsamp-DEFICIENT MICE
================================================================================

In order to study the impact of environmental manipulations on the phenotype, we exposed male Lsamp-deficient mice to environmental enrichment (EE), a technique that has often been shown to abolish phenotypic deviations in knockout mice, and to social isolation, a stressful manipulation, after which all the mice were tested in a behavioral battery. EE abolished differences between the genotypes in body weight and anogenital sniffing, a behavior related to aggressiveness, and amplified the anxiolytic-like phenotype of Lsamp-deficient mice both in the plus-maze and motility box ([@B8]). Isolation abolished differences between the genotypes in body weight and anxiety and amplified the differences in swimming speed and anogenital sniffing. EE and isolation failed to modify the results as compared to standard housing in whisker trimming, locomotor activity, marble burying, and corticosterone levels. In conclusion, Lsamp-deficient mice were less sensitive to isolation stress than their wild-type littermates. Lack of LAMP protein seemingly leads to a deterioration in the ability to adapt to novel stressful environments and stimuli ([@B8]).

GENE POLYMORPHISM STUDIES DEMONSTRATING A ROLE OF LSAMP IN MOOD DISORDERS
=========================================================================

Human data link LSAMP not only with anxiety, but also with a wider spectrum of psychiatric disorders: polymorphisms in the human LSAMP gene have been associated with panic disorder (PD; [@B10]) and male completed suicide ([@B17]). Furthermore, the levels of LAMP protein have been found to be approximately 20% increased in postmortem frontal cortex both in patients with schizophrenia and bipolar disorder ([@B2]).

Our recent studies indicate that the LSAMP gene is possibly related to major depressive disorder (MDD) and PD ([@B11]). We detected statistically significant allelic associations between four LSAMP SNPs and MDD. Two SNPs out of these four contributed to the increased risk (rs1461131 and rs4831089) and two were protective (rs16824691 and rs9874470). Interestingly, all associated SNPs in our study reside in the first intron (1b) and may affect the regulation of gene expression. Only two risk SNPs above were related to PD. Haplotype block was formed from the forenamed SNPs giving three statistically significant haplotypes in the MDD group: TATA was a risk haplotype, whereas CGAG and CGTG were protective haplotypes. The risk haplotype TATA was also statistically significant in the PD group ([@B11]). On a closer analysis of frequencies of minor alleles of haplotype block, the risk haplotype TATA appeared more frequently than the protective haplotypes CGAG and CGTG in the MDD group (41 vs 24%) as compared to their respective control group (31 vs 33%; Pearson's Chi square 10.96, *P* = 0.0009; [@B11]). The same trend was observed in the PD group where the risk haplotype TATA was more frequent than the protective haplotypes CGAG and CGTG (38 vs 28%) as compared to their respective control group (31 vs 34%). However, the difference in the case of PD did not reach to the level of statistical significance (Pearson's Chi square 3.37, *P* = 0.066). Therefore, this study ([@B11]) underlines a significantly stronger relation of the LSAMP gene polymorphisms to MDD than to PD.

STATE OF ART
============

In conclusion, the studies described above, performed in laboratory animals and psychiatric patients, suggest a possible role of LAMP in the mechanisms of psychiatric disorders. The Lsamp gene seems to be involved in the regulation of emotional behavior in rodents as the elevated function of the Lsamp gene is accompanied with increased anxiety, whereas the genetic invalidation of the Lsamp gene leads to the reduction of anxiety in rodents. There is also a shift in the expression of GABA~A~ receptor subunits in favor of alpha2. This could be a reason for the reduced anxiety and increased anxiolytic action of diazepam in Lsamp-deficient mice ([@B7]). Furthermore, the adaptation of Lsamp-deficient mice is impaired in novel and stressful environments and they display reduced aggressiveness. Also, their response to the behavioral effects of amphetamine is blunted ([@B6]). These behavioral effects are most likely related to changes in the function of the 5-HT-ergic system in Lsamp-deficient mice. Besides that we found a relation between gene polymorphisms of the LSAMP gene and MDD ([@B11]). Patients suffering from MDD have significantly increased ratio between the risk and protective haplotypes of the LSAMP gene compared to healthy subjects. The impact of these haplotypes for the function of LAMP is not clear and remains to be elucidated in future studies.
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